Elevance Health has finalized the acquisition of Verily's insurance subsidiary, Granular, marking a pivotal moment for Verily as it aims to streamline operations and concentrate on AI. CEO Stephen Gillett communicated to staff that this decision is a strategic win and will bolster Verily's financial position, enabling the company to reinvest in its core priorities. The acquisition comes as Verily sheds multiple projects and seeks to reinforce its identity beyond Alphabetâs vast offerings, focusing primarily on the future of healthcare technology and AI.
Verily's acquisition of its stop-loss insurance subsidiary to Elevance Health strengthens its financial position and allows reinvestment towards strategic AI priorities.
Verily, seen as one of Alphabet's 'other bets', has pivoted from diverse projects to a focused strategy around AI and financial strengthening.
Collection
[
|
...
]